Deutsche Bank
RLAY icon

Deutsche Bank’s Relay Therapeutics RLAY Stock Holding History

Deutsche Bank’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.07M Buy
164,036
+34,424
+27% +$500K ﹤0.01% 1657
2026
Q1 		$1.29M Buy
129,612
+5,618
+5% +$50.3K ﹤0.01% 2033
2025
Q4 		$1.05M Buy
123,994
+3,803
+3% +$27.1K ﹤0.01% 2168
2025
Q3 		$627K Buy
120,191
+10,404
+9% +$39.7K ﹤0.01% 2433
2025
Q2 		$380K Buy
109,787
+39,018
+55% +$116K ﹤0.01% 2601
2025
Q1 		$185K Sell
70,769
-11,691
-14% -$45.8K ﹤0.01% 2984
2024
Q4 		$340K Buy
82,460
+30,278
+58% +$165K ﹤0.01% 2827
2024
Q3 		$369K Buy
52,182
+14,212
+37% +$106K ﹤0.01% 2624
2024
Q2 		$248K Sell
37,970
-13,645
-26% -$93.2K ﹤0.01% 2687
2024
Q1 		$428K Buy
51,615
+1,248
+2% +$12.2K ﹤0.01% 2421
2023
Q4 		$555K Sell
50,367
-1,412
-3% -$11.9K ﹤0.01% 2334
2023
Q3 		$435K Buy
51,779
+6,119
+13% +$65.8K ﹤0.01% 2256
2023
Q2 		$573K Sell
45,660
-111,683
-71% -$1.39M ﹤0.01% 2283
2023
Q1 		$2.59M Sell
157,343
-79,621
-34% -$1.43M ﹤0.01% 1542
2022
Q4 		$3.54M Sell
236,964
-153,144
-39% -$2.93M ﹤0.01% 1360
2022
Q3 		$8.73M Buy
390,108
+230,993
+145% +$5.07M 0.01% 1003
2022
Q2 		$2.67M Buy
159,115
+61,336
+63% +$1.31M ﹤0.01% 1604
2022
Q1 		$2.93M Sell
97,779
-2,439
-2% -$59.2K ﹤0.01% 1674
2021
Q4 		$3.08M Buy
100,218
+57,417
+134% +$1.81M ﹤0.01% 1720
2021
Q3 		$1.35M Buy
42,801
+3,912
+10% +$132K ﹤0.01% 2420
2021
Q2 		$1.42M Buy
38,889
+7,144
+23% +$235K ﹤0.01% 2539
2021
Q1 		$1.1M Buy
31,745
+6,608
+26% +$287K ﹤0.01% 2604
2020
Q4 		$1.04M Buy
25,137
+7,922
+46% +$358K ﹤0.01% 2411
2020
Q3 		$733K Buy
+17,215
New +$656K ﹤0.01% 2399

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Deutsche Bank's RLAY Position: Q2 2026 in Review

Deutsche Bank increased its Relay Therapeutics (RLAY) stake by 27% in Q2 2026, buying an estimated $500K and bringing the position to 164,036 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

Deutsche Bank first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. The position peaked at $8.73M in Q3 2022. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Deutsche Bank held 164,036 shares of Relay Therapeutics worth $3.07M as of Q2 2026.
  • Deutsche Bank bought 34,424 Relay Therapeutics shares in Q2 2026, an estimated $500K.
  • Relay Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1657 holding.
  • Deutsche Bank first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Deutsche Bank's Relay Therapeutics position peaked at $8.73M in Q3 2022.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.